Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 331 AL 345

PUBMED

Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.

Whittaker DS, Loh DH, Wang HB, Tahara Y, Kuljis D, Cutler T, Ghiani CA, Shibata S, Block GD, Colwell CS.

J Biol Rhythms. 2018 Aug 7:748730418790401. doi: 10.1177/0748730418790401. [Epub ahead of print]

0

0

0

PUBMED

Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Fritz NE, Boileau NR, Stout JC, Ready R, Perlmutter JS, Paulsen JS, Quaid K, Barton S, McCormack MK, Perlman SL, Carlozzi NE; Huntington Disease Quality of Life Site Investigators and Coordinators, Un

J Neuropsychiatry Clin Neurosci. 2018 Mar 21:appineuropsych17080173. doi: 10.1176/appi.neuropsych.17080173. [Epub ahead of print]

0

0

0

PUBMED

Skeletal Muscle Modulates Huntington's Disease Pathogenesis in Mice: Role of Physical Exercise.

Corrochano S, Blanco G, Acevedo-Arozena A.

J Exp Neurosci. 2018 Oct 30;12:1179069518809059. doi: 10.1177/1179069518809059. eCollection 2018.

0

0

0

PUBMED

Multiple Causes of Pediatric Early Onset Chorea-Clinical and Genetic Approach.

Blumkin L, Lerman-Sagie T, Westenberger A, Ben-Pazi H, Zerem A, Yosovich K, Lev D.

Neuropediatrics. 2018 May 25. doi: 10.1055/s-0038-1645884. [Epub ahead of print]

0

0

0

PUBMED

Platelet-derived extracellular vesicles in Huntington's disease.

Denis HL, Lamontagne-Proulx J, St-Amour I, Mason SL, Weiss A, Chouinard S, Barker RA, Boilard E, Cicchetti F.

J Neurol. 2018 Sep 12. doi: 10.1007/s00415-018-9022-5. [Epub ahead of print]

0

0

0

PUBMED

Systematic genetic interaction studies identify histone demethylase Utx as potential target for ameliorating Huntington's disease.

Song W, Zsindely N, Faragó A, Marsh JL, Bodai L.

Hum Mol Genet. 2018 Feb 15;27(4):759. doi: 10.1093/hmg/ddy020. No abstract available.

0

0

0

PUBMED

Human cellular models of medium spiny neuron development and Huntington disease.

Golas MM.

Life Sci. 2018 Jul 18. pii: S0024-3205(18)30407-7. doi: 10.1016/j.lfs.2018.07.030. [Epub ahead of print] Review.

0

0

0

PUBMED

Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington's Disease Mice.

da Fonsêca VS, da Silva Colla AR, de Paula Nascimento-Castro C, Plácido E, Rosa JM, Farina M, Gil-Mohapel J, Rodrigues ALS, Brocardo PS.

Mol Neurobiol. 2018 Jan 31. doi: 10.1007/s12035-018-0890-6. [Epub ahead of print]

0

0

0

PUBMED

Neuronal adenosine A(2A) receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington's disease.

Domenici MR, Chiodi V, Averna M, Armida M, Pèzzola A, Pepponi R, Ferrante A, Bader M, Fuxe K, Popoli P.

Purinergic Signal. 2018 May 16. doi: 10.1007/s11302-018-9609-4. [Epub ahead of print]

0

0

0

PUBMED

Striatal Direct and Indirect Pathway Output Structures Are Differentially Altered in Mouse Models of Huntington's Disease.

Barry J, Akopian G, Cepeda C, Levine MS.

J Neurosci. 2018 May 16;38(20):4678-4694. doi: 10.1523/JNEUROSCI.0434-18.2018. Epub 2018 Apr 24.

0

0

0

PUBMED

Altered excitability and exocytosis in chromaffin cells from the R6/1 mouse model of Huntington's disease is linked to overexpression of mutated huntingtin.

Martínez-Ramírez C, Baraibar AM, Nanclares C, Méndez-López I, Gómez A, Muñoz MP, de Diego AMG, Gandía L, Casarejos MJ, García AG.

J Neurochem. 2018 Sep 5. doi: 10.1111/jnc.14585. [Epub ahead of print]

0

0

0

PUBMED

Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism.

Skotte NH, Andersen JV, Santos A, Aldana BI, Willert CW, Nørremølle A, Waagepetersen HS, Nielsen ML.

Cell Rep. 2018 May 15;23(7):2211-2224. doi: 10.1016/j.celrep.2018.04.052.

0

0

0

PUBMED

Meldonium improves Huntington's disease mitochondrial dysfunction by restoring peroxisome proliferator-activated receptor γ coactivator 1α expression.

Di Cristo F, Finicelli M, Digilio FA, Paladino S, Valentino A, Scialò F, D'Apolito M, Saturnino C, Galderisi U, Giordano A, Melone MAB, Peluso G.

J Cell Physiol. 2018 Oct 26. doi: 10.1002/jcp.27602. [Epub ahead of print]

0

0

0

PUBMED

Huntington's disease: Neuropsychiatric manifestations of Huntington's disease.

Goh AM, Wibawa P, Loi SM, Walterfang M, Velakoulis D, Looi JC.

Australas Psychiatry. 2018 Aug;26(4):366-375. doi: 10.1177/1039856218791036. Epub 2018 Jul 16.

0

0

0

PUBMED

Improvement of BDNF signalling by P42 peptide in Huntington's disease.

Couly S, Paucard A, Bonneaud N, Maurice T, Benigno L, Jourdan C, Cohen-Solal C, Vignes M, Maschat F.

Hum Mol Genet. 2018 Jun 1. doi: 10.1093/hmg/ddy207. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy